nucleoli and abundant amphophilic staining cytoplasm. Many areas consisted of spindle-shaped cells arranged in characteristic storiform pattern ( Figure  1 ). There were dilated blood vessels surrounded by tumour cells. Extensive areas ofnecrosis were visible but there was no evidence of epithelial malignancy. Oil red 0 stains revealed no fat within the tumour cells. PTAH, PAS and mucicarmine stains were also negative. Histologically, it was a typical MFH.
Discussion
MFH, predominantly a tumour of adult life, is uncommon in childhood1'2. The tumour typically occurs on the extremities and retroperitoneum. The abdominal tu'mours may produce signs of increased intra-abdominal pressure, resulting in hernia and abdominal distension1. One case of intestinal MFH causing intussusception has been reported4. The clinical presentation in our case is unique in that the tumour caused ileal perforatjon.
MFH is a morphologically heterogeneous neoplasm usually composed of rounded and spindle cells arranged in a storiform pattem accompanied by pleomorphic giant cells and inflammatory cells"5.
Because of its variable morphologic pattern, this tumour has often been confused with pleomorphic liposarcoma, rhabdomyosarcoma and anaplastic carcinoma. Our case conformed to the criteria for MFH, there being no elements to confuse it with the entities mentioned above.
Biologically, MFH is a highly malignant sarcoma with a two-year survival ofabout 50% and a high rate of recurrence and metastases"6. Early and complete removal of the tumour is advised as the best method of improving survival. The biological potential and pathological criteria for prognosis in MFH of the intestine have yet to be determined.
The most controvet-sial aspect of MFH is its histogenesis. Although it has been considered by some investigators to be of histiocytic-origili6'7, others have suggested an origin from a primitive mesenchymal cell8. The precise histogenesis of MFH remains uncertain and more sophisticated techniques may be required to characterize them further, particularly in MFH ofthe intestine.
Our patient developed ileal perforation because of rapid growth and extensive necrosis in the tumour.'It might therefore be expected that MFH-of the bowel would commonly present with perforation. The very rare occurrence of MFH in the intestine may be the major reason whyv-this complication has not been reported previously. A history of unsteadiness, with the finding on examination of peripheral weakness and absent ankle jerks, is u<uially suggestive of a neurological disorder. We report such a patient who on; further examination proved to have an unusual orthopaedic problem which is a recognized but rare complication of steroid therapy.
Case report A43-year-old housewife suddenlydevelopedunsteadiness of gait, which persisted. She complained of a constant tendency to fall forwards. Hier only other symptom was of a vague and not troublesome ache in both ankles. She gave no other history suggestive of neurological disease or of trauma. She had been asthmatic since the age of 7. and had taken short courses of oral steroids for acute exacerbations for many years; in addition she had been taking oral prednisolone 10 mg daily for the twelve -months before presentation. She also took terbutaline and slow theophylline orally, and salbutamol and beclomethasone by inhaler. On presentation to her local hospital 9 weeks after the onset of-symptoms she was found to have absent ankle jerks, and was referred to our department as a neurological problem. On examination she was, mildly Cushingoid. General examination was otherwise normal. Neurologically, there were no abnormalities ofhigher functions, cranial nerves or upper limbs. In the lower limbs power was grade 5 (MRC scale) in all muscle groups except for ankle plantar flexion which was grade 3 bilaterally.
There was no muscle wasting or fasciculation. Tone, coordination and sensation were normal, as 0141-0768/87/ 060886-O2/$02,00/0°1 987 The Royal Society of Medicine were knee jerks and plantar responses. Ankle jerks were unobtainable. Romberg's sign was strongly positive and gait was unsteady and broad-based with a tendency to fall forwards. There was tenderness over both Achilles tendons, in which defects could be felt about 3 cm proximal to the calcaneal insertions. Passive dorsiflexion of the ankles was possible to 300 beyond the neutral position and plantar flexion failed to occur on calf compression.
The following investigations were normal or negative: X-rays of spine, ankles and chest, full blood count, ESR, glucose tolerance test, serum electrolytes and bone profile, fasting lipid profile, and antinuclear and rheumatoid factors.
It was concluded that her entire clinical picture was due to bilateral spontaneous rupture of her Achilles tendons. Because of the duration of the history, her steroid therapy, and the retention of some plantar flexion ability, she was treated conservatively with light short leg casts (Baycast) in equinus which permitted satisfactory and painless mobility. These were removed after five weeks and it was found that her gait was considerably more steady although ankle plantar flexion was still weak. Her oral steroids were reduced slowly with a concomitant increase in her other medication and without deterioration in her asthma.
Bilateral Achilles tendon rupture has been reported as a complication of corticosteroids given either by local injection' or orally. In the latter instance it has been suggested that the primary disease process being treated, for example systemic lupus erythema-tosus2, is the most important aetiological factor. This seems unlikely as several cases of rupture have been documented in which patients were taking longterm oral steroids for respiratory disease without demonstrable connective tissue disease3'4. Degenerative changes are normally found in Achilles tendons after the third decade' and corticosteroids presumably cause rupture through suppression ofrepair mechanisms, so that apparently spontaneous rupture will occur after minimal trauma not noticed by the patient.
Previous reports of bilateral Achilles tendon rupture following steroid therapy-describe pain as the major symptom, in contrast to our patient who had minimal discomfort but marked unsteadiness of gait.
In conclusion, we suggest that difficulty in walking or the finding of 'neurological' signs in a patient on steroid therapy should lead to 'consideration of this unusual orthopaedic complication. The psychiatric side effects oflong-term, high-dosage bromocriptine treatment for parkinsonism are well known. We report a young woman with no history of affective disorder who required compulsory admission fora, bipolar disorder associated with bromocriptine therapy for postpartum galactorrhoea. General practitioners and midwives should be. aware of the possible psychiatric side effects of bromocriptine therapy.
Case report
A 30-year-old woman was compulsory admitted under the Dutch mental health act and diagnosed as having a puerperal psychosis 15 days after the rapid delivery of her first pregnancy.
After delivery, therapy with bromocriptine 2.5 mg twice-daily had been initiated to stop galactorrhoea. Thereafter she slept little, became restless and uninhibited, talked day and night and was continually active and sometimes verbally aggressive. She had the magical idea that by talking about problems a bad ghost would escape from her. She refused voluntary admission and locked herself up in a room with the baby and, when coming out, was involuntarily admitted. There was no history nor family history of psychiatric pathology.
On admission she was slightly agitated, restless, talkative and easily distractable. Her thinking was quick and associative, her mood changed from euphoric to dysphoric, and she had preoccupations with going home. She was busy with her make-up and fingernails. Insight into her situation was lacking. Other examinations were normal.
The diagnosis of an atypical bipolar disorder was made, since the full manic spectrum was not present (DSM-III). Therapy with bromocriptme was stopped and an uneventful recovery occurred within one week. Follow up after discharge revealed no pathology.
Discussion
Bromocriptine is used in the treatment of a variety of disorders including Parkinson's disease, pituitary pathology, postpartum galactorrhoea and tardive 0141-0768/87/ 060887-02/$02.00/0 @ 1987 The Royal Society of Medicine
